MIRA INFORM REPORT

 

 

Report Date :

03.01.2012

 

IDENTIFICATION DETAILS

 

Name :

AYUKALP UAP PHARMA PRIVATE LIMITED (w.e.f. 28.02.2011)

 

 

Formerly Known As :

UNJHA AYUPHARMA PRIVATE LIMITED

 

 

Registered Office :

Mahagujarat Industrial Estate, Plot No. 423/98-A/988, Sarkhej Kawala Road, Village Moraiya, Taluka Sanand, District Ahmedabad – 382 210, Gujarat   

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

11.05.1999

 

 

Com. Reg. No.:

04-35977

 

 

Capital Investment / Paid-up Capital :

Rs.0.100 million

 

 

CIN No.:

[Company Identification No.]

U24231GJ1999PTC035977

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

AHMA10498F

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Distributor of Ayurvedic Medicine.

 

 

No. of Employees :

100 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca (17)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is a company having moderate track. There appears some accumulated losses recorded by the company. However, business is active. Payments are reported to be slow.

 

The company can be considered for business dealings on a secured trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

INFORMATION PARTED BY

 

Name :

Mr. Nitin Shah

Designation :

Director

Contact No.:

91-9825030795

Date :

05.12.2011

 

 

LOCATIONS

 

Registered Office/Factory :

Mahagujarat Industrial Estate, Plot No. 423/98-A/988, Sarkhej Kawala Road, Village Moraiya, Taluka Sanand, District Ahmedabad – 382 210, Gujarat, India    

Tel. No.:

91-2717-296082 / 83

Mobile No.:

91-9825030795 (Mr. Nitin Shah)

Fax No.:

91-2717-296083

E-Mail :

nitinshah@ayukalpuappharma.com

office_deepakcgandhi@rediffmail.com

Location :

Owned

 

 

DIRECTORS

 

As on 30.09.2011

 

Name :

Mr. Nitinbhai Vasantlal Shah

Designation :

Director

Address :

6, Tolak Nagar Society, Near Mahalaxmi Cross Road, Ahmedabad, Gujarat, India

Date of Appointment :

11.05.1999

DIN No.:

00498420

Other Directorship

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Company Status

Defaulting status

1

U24231GJ1999PTC035977

Ayukalp UAP Pharma Private Limited

Director

11-05-99

11-05-99

Active

NO

2

U24230GJ1991PTC015676

UAP Pharma Private Limited

Managing director

15-03-08

10-12-99

Active

NO

3

U85300GJ1995PLC025452

Ayukalp Industries Limited

Director

16-08-04

16-08-04

Active

NO

 

 

 

Name :

Mrs. Veena Nitinbhai Shah

Designation :

Director

Address :

6, Tolak Nagar Society, Near Mahalaxmi Cross Road, Ahmedabad, Gujarat, India

Date of Appointment :

17.01.2011

DIN No.:                   

02418324

Other Directorship

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Company Status

Defaulting status

1

U85300GJ1995PLC025452

Ayukalp Industries Limited

Director

16-08-04

16-08-04

Active

NO

2

U24231GJ1999PTC035977

Ayukalp UAP Pharma Private Limited

Director

17-01-11

17-01-11

Active

NO

 

 

 

Name :

Mr. Kuntal Nitinbhai Shah

Designation :

Director

Address :

6, Tolak Nagar Society, Near Mahalaxmi Cross Road, Ahmedabad, Gujarat, India

Date of Appointment :

17.01.2011

DIN No.:

00520987

Other Directorship

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Company Status

Defaulting status

1

U24230GJ1991PTC015676

UAP Pharma Private Limited

Director

15-03-08

21-06-01

Active

NO

2

U85300GJ1995PLC025452

Ayukalp Industries Limited

Director

02-09-04

02-09-04

Active

NO

3

U24231GJ1999PTC035977

Ayukalp UAP Pharma Private Limited

Director

17-01-11

17-01-11

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011

 

Names of Shareholders

 

No. of Shares

Ayukalp Industries

 

5000

Nitinbhai Vasantlal Shah

 

5000

Total

 

10000


As on 30.09.2011

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Bodies corporate

 

50.00

Directors or relatives of directors

 

50.00

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Distributor of Ayurvedic Medicine.

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

GENERAL INFORMATION

 

Customers :

·         Wholesalers

·         Retailers

·         End Users

 

 

No. of Employees :

100 (Approximately)

 

 

Bankers :                            

·         Oriental Bank of Commerce, Moraiya Branch 

·         ICICI Bank

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Kantawala and Associates

Chartered Accountants 

Address :

305, City Square, Near Jahanvi Restaurant, Gulbai Tekra, Ahmedabad – 380 015, Gujarat, India 

Tel. No.:

91-79-26303177

Mobile No.:

91-9376274055

Fax No.:

91-79-26307999

E-Mail :

parthivkantawala@gmail.com

PAN No.:

AHEPK1061A

 

 

Associates :

UAP Pharma Private Limited

 


 

CAPITAL STRUCTURE

 

As on 30.09.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

100000

Equity Shares

Rs.10/- each

Rs.1.000 million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

10000

Equity Shares

Rs.10/- each

Rs.0.100 million

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.100

0.100

0.100

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

0.000

0.000

0.000

4] (Accumulated Losses)

(0.045)

(0.039)

(0.043)

NETWORTH

0.055

0.061

0.057

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

0.000

0.000

0.000

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

0.055

0.061

0.057

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

0.000

0.000

0.000

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.003

0.002

0.001

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

0.000

0.000

0.000

 

Sundry Debtors

0.000

0.000

0.000

 

Cash & Bank Balances

0.049

0.003

0.003

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

0.003

0.066

0.060

Total Current Assets

0.052

0.069

0.063

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

0.000

0.010

0.007

 

Other Current Liabilities

0.000

0.000

0.000

 

Provisions

0.000

0.000

0.000

Total Current Liabilities

0.000

0.010

0.007

Net Current Assets

0.052

0.059

0.056

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

0.055

0.061

0.057

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Interest Income

0.000

0.006

0.008

 

 

TOTAL                                    

0.000

0.006

0.008

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Administrative Expenses

0.006

0.004

0.050

 

 

TOTAL                                    

0.006

0.004

0.050

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX

(0.006)

0.002

(0.042)

 

 

 

 

 

Less

TAX                                                                 

0.000

(0.001)

(0.001)

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX

(0.006)

0.003

(0.041)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(0.039)

(0.042)

(0.001)

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

(0.045)

(0.039)

(0.042)

 

 

 

 

 

 

Earnings Per Share (Rs.)

(0.56)

0.33

(4.16)

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

0.00

50.00

(512.50)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

0.00

33.33

(525.00)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(11.54)

2.90

(66.67)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.11)

0.03

(0.74)

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.00

0.16

0.12

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.00

6.90

9.00

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

 

1.

Year of Establishment

YES

2.

Locality of the firm

YES

3.

Constitutions of the firm

YES

4.

Premises details

YES

5.

Type of Business

YES

6.

Line of Business

YES

7.

Promoter’s background

--

8.

No. of employees

YES

9.

Name of person contacted

YES

10.

Designation of contact person

YES

11.

Turnover of firm for last three years

NO

12.

Profitability for last three years

--

13.

Reasons for variations <> 20%

NO

14.

Estimation for coming financial year

NO

15.

Capital in the business

NO

16.

Details of sister concerns

--

17.

Major Suppliers

NO

18.

Major Customers

NO

19.

Payment terms

YES

20.

Export / Import details (is applicable)

--

21.

Market information

--

22.

Litigation that the firm / promoter involved in

--

23.

Banking Details

YES

24.

Banking facility details

--

25.

Conduct of the banking account

--

26.

Buyer visit details

--

27.

Financials, if provided

NO

28.

Incorporation details, if applicable

--

29.

Last accounts filed at ROC

--

30.

Major Shareholders, is available

--

 

FINANCIAL RESULTS

 

The company has incurred loss of Rs.0.006 million after providing Deferred Tax Income of Rs.0.002 million and Income Tax Expenses Rs.0.002 million. The director hope for better result in the next year.

 

CHANGE OF NAME

 

The name of the company is already change from Unjha Ayupharma Private Limited to Ayukalp Uap Pharma Limited with effect from 28th February, 2011.

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.53.29

UK Pound

1

Rs.82.66

Euro

1

Rs.68.90

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

2

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILIRY

1~10

1

--LIQUIDITY

1~10

2

--LEVERAGE

1~10

1

--RESERVES

1~10

1

--CREDIT LINES

1~10

1

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

17

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.